360° Coverage : Risky Business: The FDA And Drug Development For The Fatally Ill

2 Updates
Risky Business: The FDA And Drug Development For The Fatally Ill
Photo Credit: Forbes Business

Risky Business: The FDA And Drug Development For The Fatally Ill

Mar 6 2014, 12:01am CST | by

If you’ve ever waited for treatment in the ER—for yourself or perhaps for a child suffering a broken bone or an asthma attack—then you’re familiar with how agonizing it can be, knowing that the...

Filed under: news

 
 
 

28 weeks ago

Risky Business: The FDA And Drug Development For The Fatally Ill

Mar 6 2014, 12:01am CST | by

If you’ve ever waited for treatment in the ER—for yourself or perhaps for a child suffering a broken bone or an asthma attack—then you’re familiar with how agonizing it can be, knowing that the answer might be just on the other side of the swinging doors. For parents of seriously ill children, this kind of waiting can last for years. And when treatment options are still stuck in the development, testing, or approval processes, the wait can cost patients their lives.

The FDA has set up these processes for good reason; they protect the public from experiencing severe, unexpected side effects due to unsafe drugs, which could actually make people even sicker than they already were. But for seriously ill patients, sometimes the risk is worth taking if there’s any chance of increasing their survival rates. In these cases, the burdensome approval process to get drugs on the market—which can take up to 18 years—is detrimental both to pharmaceutical companies and to patients. The recent controversy over the FDA’s refusal to approve eteplirsen, a drug intended to treat Duchenne muscular dystrophy, is a prime example of this. Eteplirsen has shown some promising results in clinical trials, but the data still isn’t satisfactory enough for FDA approval, since it has a hard time assessing benefit and risk across a spectrum of perspectives and experiences. Patients and their families beg for access to the drug, to no avail.

Unlike other industries, pharmaceutical companies are also legally restricted from directly marketing to consumers or including them in the prototyping phase of the design process. This can prevent consumers from providing vital feedback that could shape drug effectiveness, as well as from learning about experimental options when they are available. With most conditions, the risks of experimentation would be too high. But if you had a fatal disease and were told you only had one year to live, wouldn’t you prefer to be allowed to make your own choice?

Sharon Terry, an Ashoka Fellow, and Genetic Alliance have developed a platform that facilitates the responsible engagement of the FDA with patients such as these, and they’re getting patients directly involved in voicing their concerns about the current system. The FDA’s initiative is called Patient-Focused Drug Development (PFDD), and it is designed to assess risks and benefits for specific patient communities.  Genetic Alliance is crowdsourcing input for the FDA to hear from patients.  Terry hopes to increase the available pool of information—information about patients’ genetics and other personal data—to help accelerate discovery. She’d like to see a systemic solution across all diseases, rather than solutions that work on a case by case basis.  To do that, she and her partners are putting in place a structure to empower disease groups and patients to vocalize their needs to the FDA and determine how and with whom their data is shared. Currently Genetic Alliance works with eight disease groups on PFDD and has enabled patients from each community to serve as guides with the goal of getting input from patient communities. It hopes to expand its work to more diseases in the next few years, and eventually to every disease.

Terry’s initiative has recently been awarded a $1 million contract from the Patient Centered Outcomes Research Institute to be a part of the National Patient Centered Clinical Research Network. This news could mean big things ahead for patients with genetic diseases.

If their work is successful, the FDA will begin to distinguish between the process for approving standard use drugs and the process for approving drugs that are designed to treat or cure severe disease. With increased collaboration between pharmaceutical companies and patients with a high risk tolerance, the FDA can gain data to stand on, which could help speed up drug patent approval. Patients would also be able to participate in drug design, thus improving the development process.

By challenging some of the obstacles that prevent access to potentially life-saving medicine, it may be possible to empower families to stop waiting and start acting. Risky? Maybe. But thousands of families risk even more every day.

This post is part of a series of essays on the power and potential of feedback loops to dramatically increase social impact (see the first one here). This work is being catalyzed by Feedback Labs with support from the Rita Allen Foundation.

Come join us here.

Source: Forbes Business

 
Update
2

3 weeks ago

Khazanah throws MAS RM6b lifeline

Aug 29 2014 5:01pm CDT | Source: Business Times Singapore

August 30, 2014 1:15 AMKHAZANAH Nasional will inject RM6 billion (SS$2.4 billion) over three years to resuscitate loss-making Malaysia Airlines (MAS) under a recovery plan that includes even an Act of Parliament. Other key moves are migrating its operations, assets and liabilities to a new company (NewCo) and slashing the workforce of 20,000 by 30 p ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 
Update
1

3 weeks ago

MAS posts loss of RM307m for Q2

Aug 28 2014 5:00pm CDT | Source: Business Times Singapore

August 29, 2014 1:13 AMMALAYSIA Airlines (MAS) registered a loss of RM307 million (S$122 million) for the second quarter to end-June, but warned of worse to come in the second half when the "full financial impact of the ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

Thousands of South Sudanese kids face starvation: Unicef
United Nations, Sep 23 (IANS) Thousands of children, up to five years age, are at a risk of dying from malnutrition in South Sudan, the Unicef has warned.
 
 
'Ebola could hit up to 1.4 mn West Africans'
Washington, Sep 23 (IANS) The number of Ebola cases in West Africa could reach as many as 550,000 to 1.4 million by Jan 20 in the worst-case scenario, the US Centers for Disease Control and Prevention ( CDC) warned in a report Tuesday.
 
 
London turns world's most expensive city
London, Sep 23 (IANS) London has overtaken Hong Kong as the world's most expensive city to live and work in, as a new study has suggested it has turned nearly twice as pricey as Sydney and four times more expensive than Rio de Janeiro. India's Mumbai was found to be at the bottom of the 12 most expensive cities report.
 
 
Woolly mammoth skeleton to be auctioned in Britain
London, Sep 23 (IANS) A woolly mammoth skeleton, having remained a part of a private collection for years in Europe, is all set to be auctioned in Britain.
 
 
 

Latest from the Network

Cairo to resume Palestinian-Israeli talks in October
Cairo/Jerusalem, Sep 23 (IANS) Egypt concluded Tuesday a new round of Palestinian-Israeli indirect peace talks in Cairo with both the sides approving the agenda of further talks scheduled for the second half of October...
Read more on Politics Balla
 
Serbia willing to support US fight against IS
Belgrade, Sep 23 (IANS) Serbia is willing to support the US in fight against the Islamic State (IS), Serbian Prime Minister Aleksandar Vucic said in letter to US President Barack Obama Tuesday. Vucic Tuesday expressed...
Read more on Politics Balla
 
Iran unveils combat drone
Tehran, Sep 23 (IANS) Iran has unveiled an unmanned aerial vehicle (UAV) armed with air defence missiles suitable for aerial combats, a media report said Tuesday while showing a footage of the new drone. The combat...
Read more on Politics Balla
 
PayPal’s New Ad Mocks Apple Pay
Apple has once again been slammed by one of its competitors, as a new PayPal ad criticizes the new Apple Pay NFC transaction service.According to the Christian Post, the ad was published on Monday in various major...
Read more on Apple Balla
 
Apple Watch Reportedly Including 512MB RAM and 4GB Internal Storage
The analysts continue to reveal more information about the specification of the Apple Watch, as a renowned predictor states that the next generation smartwatch will be equipped with a RAM of 512 GB and an internal...
Read more on Apple Balla
 
Next Model of iPad Air and iPad Mini Reportedly Releasing in October 2014 and Early 2015
The rumor about getting more new Apple products in this year has been intensified, as a new report claims that the iPad Air 2 will see its debut in the next month.According to Apple Insider, the report has been...
Read more on Apple Balla
 
Airstrikes against IS 'only the beginning': Pentagon
Washington, Sep 23 (IANS) The airstrikes on the Islamic State (IS) targets in Syria overnight Monday were "only the beginning" of a coalition effort of the US and its Arabic allies in the anti-IS fight, a Pentagon...
Read more on Politics Balla
 
Sexual violence during civil war an open wound for Nepal
Kathmandu, Sep 23 (IANS/EFE) Hundreds of Nepalese women who suffered sexual abuse during the civil war are still waiting for justice, eight years after the end of the conflict, human rights organisations reported...
Read more on Politics Balla
 
Thousands of South Sudanese kids face starvation: Unicef
United Nations, Sep 23 (IANS) Thousands of children, up to five years age, are at a risk of dying from malnutrition in South Sudan, the Unicef has warned. About 1.5 million people will be at crisis or emergency levels...
Read more on Business Balla
 
Three killed in warehouse shooting in US
Washington, Sep 23 (IANS) Three people were killed in a shooting incident which took place in a warehouse in the US state of Albama Tuesday morning, authorities said. The incident occurred in a warehouse near the...
Read more on Politics Balla